Oncology Business Week

Genta Incorporated - Presentations affirm importance of drug candidate in leukemia

Genta, Inc. - Genasense shown to enhance the antilymphoma activity of Velcade and Rituxan

Genzyme Corp. - Vascular gene expression is altered in invasive breast carcinoma

Harvard University - Finding lymph node metastases in cancer

Harvard University - Fusion of dendritic cells with myeloblasts induced anti-leukemic T cells

Howard Hughes Medical Institute - Researchers discover a stem-cell switch lurking within leukemias

Ilex Oncology, Inc. - Additional data support clofarabine promise

Institute of Pathology - RNA interference reverses multidrug resistance in gastric carcinoma cells

Introgen Therapeutics, Inc. - Advexin, chemotherapy combination shows promise in treating breast cancer

Johns Hopkins University - Environmental factors could have exposed veterans to higher risk of lung cancer

Kaohsiung Med University of Hospital - Gallbladder, bile duct cancers have different etiologies, tumorigenesis

Karolinska Institute - Platelet-derived growth factor fosters lymphatic metastasis

Karolinska University Hospital - Expression of altered P53 protein plays role in melanoma progression

Kendle International Inc. - CRO asserts pediatric trials are increasing in response to new regulations

Laboratory Corp. of America Holdings - LabCorp to acquire US Pathology Labs, Inc.

Ligand - Ontak may benefit patients with relapsed/refractory T-cell non-Hodgkin lymphoma

M.D. Anderson Cancer Center - Delta-24 adenovirus infects and kills human medulloblastoma cells

M.D. Anderson Cancer Center - Dual tyrosine kinase receptor blockade foils oral cancer progression in mice

M.D. Anderson Cancer Center - Human blood stem cells transform themselves to repair injured animal hearts

M.D. Anderson Cancer Center - The cancer-specific properties of the survivin promoter enhance gene transfer

M.D. Anderson Cancer Center - Ts1 infection of astrocytes accelerates cell death

Marques de Valdecilla University Hospital - Breast cancer cells are refractory to a new small molecule inhibitor of Bcl-2

Massachusetts General Hospital - Timing appears essential to combining antiangiogenesis and radiation therapy

Mayne Group Limited - Zydus signs MOU with oncology-focused company for manufacturing set up in India

Memorial Sloan-Kettering Cancer Center - DNA mismatch repair gene proteins reviewed

Mergers and Acquisitions - AmeriPath acquires Pathology Associates in New York

Millennium Pharmaceutical Inc. - Antibody-chemotherapeutic conjugate designed for prostate cancer therapy

Mito Medical Center - Intraepithelial CD8+ T-cell-count marks the prognosis of colorectal carcinoma

Molecular Engines Laboratories - Translationally controlled tumor protein levels decline in tumor revertants

Mt. Vernon Hospital, Northwood - Radiation-induced bystander response causes DNA double strand breaks

Nagoya University - Midkine deletion protects the kidneys against cisplatin-induced injury

National Defense Medical Center - Lymphoma patients have delayed HBV reactivation after lamivudine cessation

National Taiwan University - Arsenic ingestion from well water associated with increased risk of lung cancer

Norwood Immunology - Immunology company provides clinical trials update

Ohio State University - Cancer patients unable to intentionally postpone death for significant events

Optimata, Ltd. - Patients get individualized therapy in Nottingham Trial

Organ Transplant - Chinese hospital claims success in digestive organs transplant

Osaka City University - CD80 gene therapy disrupts the spread of gastric cancer to lymph nodes

Osaka University - Gene expression profile distinct from other diffuse large B-cell lymphomas

Peking University - BJ-HCC-20 may be a potential novel cancer-testis antigen

deCODE Genetics - Does cancer run in families?